Corcept Therapeutics | CORT - Market Capitalization



Corcept Therapeutics reported $7.27B in Market Capitalization this September of 2025, considering the latest stock price and the number of outstanding shares.


Market Capitalization Change Date
Acadia Pharmaceuticals USD 3.61B 840M Jun/2025
Alaunos Therapeutics USD 3M 2M Dec/2024
ANI Pharmaceuticals USD 1.41B 31M Jun/2025
Ardelyx USD 1.51B 568M Sep/2025
Aurora Cannabis CAD 405.84M 81.86M Sep/2025
BioMarin Pharmaceutical USD 10.54B 3.01B Jun/2025
Bristol-Myers Squibb USD 94.2B 29.9B Jun/2025
Canopy Growth CAD 225.05M 88.93M Sep/2025
Corcept Therapeutics USD 7.78B 4.27B Jun/2025
Eli Lilly USD 738.79B 2.87B Jun/2025
J&J USD 366.71B 32.94B Jun/2025
Knight Therapeutics CAD 599.03M 24.75M Sep/2024
Merck USD 198.77B 27.1B Jun/2025
Novartis CHF 256.18B 64.49B Jun/2025
Novartis USD 258.67B 24.42B Sep/2025
Pacira USD 1.11B 43M Jun/2025
Pfizer USD 137.53B 6.19B Jun/2025
Supernus Pharmaceuticals USD 1.76B 65M Jun/2025
TG Therapeutics USD 5.71B 526M Jun/2025